HomeFinancial ServicesStandard Chartered Unveils Institutional Digital Assets Trading

Standard Chartered Unveils Institutional Digital Assets Trading

Published on

spot_img

Overview:

  • Standard Chartered has launched a fully integrated digital assets trading service for institutional clients, offering spot trading for Bitcoin and Ether.
  • This makes it the first global systemically important bank to provide deliverable spot cryptoasset trading to corporates, investors, and asset managers.
  • The service is FCA-registered and operates within Standard Chartered’s regulated banking framework, ensuring robust risk controls and regulatory compliance.
  • Clients can trade through familiar FX interfaces and settle with their choice of custodian, including Standard Chartered’s own custody solutions.
  • This launch expands the bank’s digital asset capabilities, which already include custody, trading, and tokenisation services via ventures like Zodia and Libeara.

According to a press release, Standard Chartered officially launched a fully integrated digital assets trading service for institutional clients on 15 July 2025. This significant development offers secure, regulated, and scalable access to the rapidly evolving crypto market.

“We are applying our global expertise, infrastructure and risk management frameworks that our clients trust to the digital assets space,” said Tony Hall, Global Head of Trading and XVA, Markets, at Standard Chartered. “With growing interest in regulated digital assets solutions, we are well positioned to meet client needs while capturing the opportunities in this space.”

Guest idea:
Tony Hall
Global Head of Trading and XVA, Markets
Standard Chartered

More stories: Visa unlocks access to credit for 65% of Asians who don’t have it

Latest articles

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...

More like this

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...